Company Filing History:
5 out of 1,933 
1 out of 290 
1 out of 3,684 
Years Active: 2010-2014
Title: Kapil N Bhalla: Innovator in Medical Treatments
Introduction
Kapil N Bhalla is a notable inventor based in Tampa, FL (US). He has made significant contributions to the field of medical treatments, particularly in addressing complex health issues such as artery obstructive diseases and leukemia. With a total of 5 patents to his name, Bhalla's work has the potential to impact many lives.
Latest Patents
One of his latest patents focuses on the treatment of restenosis and stenosis with dasatinib. This method aims to treat or inhibit artery obstructive diseases, such as restenosis after angioplasty and stenting procedures, as well as stenosis following coronary artery bypass surgery. The patent details the administration of a therapeutically effective amount of dasatinib or its derivatives. Additionally, it includes drug-eluting medical devices, such as stents, that contain a therapeutically effective amount of dasatinib. Another significant patent by Bhalla is a leukemia treatment method and composition. This method induces high anti-leukemia activity through a combination of hydroxamic acid analogue histone deacetylase inhibitors and PKC412 against human acute leukemia, characterized by expressing phosphorylated (p)FLT3 kinase, as demonstrated by a novel flow cytometry-based assay.
Career Highlights
Kapil N Bhalla has worked with esteemed institutions, including the University of South Florida and the H. Lee Moffitt Cancer Center and Research Institute, Inc. His work in these organizations has allowed him to develop innovative solutions to pressing medical challenges.
Collaborations
Throughout his career, Bhalla has collaborated with notable colleagues, including Jie Wu and Zhengming Chen. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Kapil N Bhalla's contributions to medical innovation, particularly in the treatment of artery obstructive diseases and leukemia, highlight his role as a significant inventor in the field. His patents reflect a commitment to improving patient outcomes through advanced medical technologies.